Evaluating an Expressive Writing Intervention About Communicatively-Restricted Organizational Stressors
|ClinicalTrials.gov Identifier: NCT01328665|
Recruitment Status : Completed
First Posted : April 5, 2011
Last Update Posted : May 20, 2013
|Condition or disease||Intervention/treatment|
|Stress Disorder||Other: Expressive Writing|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||44 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Evaluating an Expressive Writing Intervention About Communicatively-Restricted Organizational Stressors: A Six-Week Randomized, Controlled Trial|
|Study Start Date :||April 2011|
|Primary Completion Date :||June 2012|
|Study Completion Date :||June 2012|
Experimental: Expressive Writing
Affectionate Writing Intervention for 20 minutes per day, 2 times per week, 6 weeks.
Other: Expressive Writing
Writing intervention for cognitive appraisal of stressor.
No Intervention: No writing
Control Group -- No writing
- Change in Lipids from baseline [ Time Frame: Week 1 and Week 6 ]Lipid panel includes total cholesterol, High-density lipoproteins, low-density lipoprotein, and triglycerides.
- Change in high-sensitivity c-Reactive Protein from baseline [ Time Frame: Week 1 and Week 6 ]
- Change in Cortisol Awakening Response from Baseline [ Time Frame: Week 1 and Week 6 ]Measurement of Salivary Cortisol (hydrocortisone, compound-F) as a maximum difference between awakening and 30 minutes after awakening.
- Change in Perceived Global Stress over time [ Time Frame: Week 1, Week 3, Week 6 ]Psychological measure of stress
- Change in Organizational Stress over time [ Time Frame: Week 1, Week 3, Week 6 ]Psychological measure of stress as a function of organizational involvement.
- Change in Perception of Communication Restriction of Stressor over time [ Time Frame: Week 1, Week 3, Week 6 ]Restrictedness of a communicative stressor
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01328665
|United States, California|
|Santa Clara University, Health Center|
|Santa Clara, California, United States, 95053|
|Principal Investigator:||Justin P Boren, Ph.D.||Santa Clara University|